Search Results
- < Prev
1 of 1
- Next >
News Releases
-
May 07, 2013, 16:30 ET
Keryx Biopharmaceuticals, Inc. Announces First Quarter 2013 Financial Results
Keryx Biopharmaceuticals, Inc. (NASDAQ: KERX), a biopharmaceutical company focused on the acquisition, development and commercialization of medically important pharmaceutical products for the treatment of renal disease (the "Company"), today announced its results for the first quarter ended...
More news about: Keryx Biopharmaceuticals, Inc.
-
May 06, 2013, 16:30 ET
Keryx Biopharmaceuticals, Inc. To Host Conference Call on First Quarter 2013 Financial Results
Keryx Biopharmaceuticals, Inc. (NASDAQ: KERX), a biopharmaceutical company focused on the acquisition, development and commercialization of medically important pharmaceutical products for the treatment of renal disease, today announced that a conference call will be held on Wednesday, May 8,...
More news about: Keryx Biopharmaceuticals, Inc.
- < Prev
1 of 1
- Next >
Modify your Search
 |
Quickly search for PR Newswire releases by adding our plugin to your browser search |